Neuroone Medical Technologies

Yahoo Finance • 6 days ago

NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ...

Release Date: January 10, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points NeuroOne Medical Technologies Corp (NASDAQ:NMTC) has three FDA 510(k) cleared electrode... Full story

Yahoo Finance • 23 days ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering... Full story

Yahoo Finance • 24 days ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

EDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering... Full story

Yahoo Finance • last month

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update

EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for pati... Full story

Yahoo Finance • last month

NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) --  Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) CEO Dave Rosa and Jessica Clark, DNP, RN, Dean of the College... Full story

Yahoo Finance • 2 months ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for pati... Full story

Yahoo Finance • 3 months ago

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patie... Full story

Yahoo Finance • 3 months ago

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

EDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patie... Full story

Yahoo Finance • last year

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

Patent allowance strengthens IP portfolio and positions company in pursuing drug delivery using its neural probes EDEN PRAIRIE, Minn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne... Full story

Yahoo Finance • last year

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Volker strengthens existing management team in areas of commercialization, business development, and reimbursement EDEN PRAIRIE, Minn., Nov. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOn... Full story

Yahoo Finance • last year

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

Feedback from responses to FDA anticipated in 30 days Commercialization remains on track in first half of 2024 pending FDA clearance Product potential for transformative improvement in neurosurgery as first known sEEG-guided RF system th... Full story

Yahoo Finance • 2 years ago

NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023

EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patie... Full story

Yahoo Finance • 2 years ago

NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference

EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for pati... Full story

Yahoo Finance • 2 years ago

NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patie... Full story

Yahoo Finance • 2 years ago

NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System 

Potential for transformative improvement in neurosurgery as first known sEEG-guided RF system thatrecords and ablates nervous tissue with the added benefit of temperature control EDEN PRAIRIE, Minn., June 12, 2023 (GLOBE NEWSWIRE) -- Ne... Full story

Yahoo Finance • 2 years ago

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery

Evo sEEG electrode used with Zimmer Biomet’s ROSA One® Brainduring procedure at Cleveland Clinic EDEN PRAIRIE, Minn., May 17, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"... Full story

Yahoo Finance • 2 years ago

NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11

EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patien... Full story

Yahoo Finance • 2 years ago

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic

Evo sEEG electrodes used for brain mapping in epilepsy surgery EDEN PRAIRIE, Minn., May 10, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company fo... Full story

Yahoo Finance • 2 years ago

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patien... Full story

Yahoo Finance • 2 years ago

NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10

EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patien... Full story